| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 255.75B | 269.86B | 247.89B | 222.32B | 212.07B | 198.16B |
| Gross Profit | 40.55B | 40.51B | 37.37B | 32.16B | 30.02B | 28.97B |
| EBITDA | 38.98B | 41.24B | 38.61B | 33.72B | 31.89B | 30.75B |
| Net Income | 14.99B | 18.24B | 16.55B | 16.61B | 15.91B | 14.74B |
Balance Sheet | ||||||
| Total Assets | 434.28B | 436.39B | 431.74B | 393.76B | 360.75B | 339.48B |
| Cash, Cash Equivalents and Short-Term Investments | 44.95B | 37.51B | 36.78B | 43.85B | 40.49B | 30.68B |
| Total Debt | 128.08B | 135.93B | 123.23B | 83.91B | 77.75B | 69.62B |
| Total Liabilities | 185.62B | 193.58B | 182.06B | 147.31B | 131.35B | 120.44B |
| Stockholders Equity | 241.21B | 237.89B | 241.78B | 246.10B | 229.09B | 218.71B |
Cash Flow | ||||||
| Free Cash Flow | -3.52B | 11.28B | 954.00M | 7.59B | 10.31B | -3.25B |
| Operating Cash Flow | 13.38B | 38.16B | 27.64B | 31.11B | 32.55B | 28.98B |
| Investing Cash Flow | -26.72B | -25.56B | -53.98B | -24.34B | -22.55B | -31.57B |
| Financing Cash Flow | 12.61B | -11.12B | 19.08B | -4.41B | -208.00M | 759.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | ¥748.05B | 38.89 | 6.79% | 1.86% | 8.86% | 14.05% | |
65 Neutral | ¥535.51B | 9.48 | 13.93% | 2.81% | -3.74% | 81.14% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
60 Neutral | ¥903.01B | 14.36 | 9.97% | 3.54% | 11.19% | 5.65% | |
59 Neutral | ¥324.59B | 16.46 | 8.30% | 2.50% | 5.27% | -5.79% | |
59 Neutral | ¥292.85B | 16.90 | ― | 2.94% | 1.47% | -10.54% | |
56 Neutral | ¥1.25T | 208.13 | ― | 2.99% | -0.90% | -81.16% |